Ligand Pharma (NASDAQ: LGND) is lower early Tuesday after announcing the signing of a license agreement with Sermonix Pharmaceuticals LLC ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE